GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,448,000 | -18.7% | 82,663 | -1.7% | 0.01% | -16.7% |
Q2 2023 | $3,011,000 | +40.6% | 84,116 | -7.9% | 0.01% | +20.0% |
Q1 2023 | $2,142,000 | +30.0% | 91,372 | +50.5% | 0.01% | +25.0% |
Q4 2022 | $1,648,000 | -53.0% | 60,730 | -6.8% | 0.00% | -55.6% |
Q3 2022 | $3,506,000 | +30.4% | 65,152 | -2.3% | 0.01% | +28.6% |
Q2 2022 | $2,688,000 | -41.6% | 66,670 | -4.0% | 0.01% | -30.0% |
Q1 2022 | $4,602,000 | -35.2% | 69,451 | -2.2% | 0.01% | -37.5% |
Q4 2021 | $7,102,000 | -23.9% | 70,995 | -10.7% | 0.02% | -36.0% |
Q3 2021 | $9,330,000 | +7.0% | 79,539 | +7.3% | 0.02% | 0.0% |
Q2 2021 | $8,723,000 | -18.2% | 74,126 | +7.3% | 0.02% | -24.2% |
Q1 2021 | $10,669,000 | +9.0% | 69,083 | -5.0% | 0.03% | -19.5% |
Q4 2020 | $9,787,000 | +34.9% | 72,727 | +12.1% | 0.04% | +17.1% |
Q3 2020 | $7,253,000 | +44.1% | 64,888 | +4.6% | 0.04% | +29.6% |
Q2 2020 | $5,034,000 | +19.8% | 62,052 | +2.8% | 0.03% | 0.0% |
Q1 2020 | $4,201,000 | -18.0% | 60,368 | -8.0% | 0.03% | -10.0% |
Q4 2019 | $5,126,000 | +33.4% | 65,603 | +9.0% | 0.03% | +42.9% |
Q3 2019 | $3,844,000 | -22.4% | 60,208 | +5.0% | 0.02% | -27.6% |
Q2 2019 | $4,951,000 | – | 57,353 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |